Itruvone

DB21543InvestigationalSmall molecule

Itruvone is a small molecule drug. Itruvone is under investigation in clinical trial NCT02322086 (A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10).... Itruvone has a monoisotopic molecular weight of 296.21 Da.

Formula / weight: C₂₁H₂₈O · 296.454 g/mol (avg)
Code names: PH-10

Resolves to

Compound

UNII72HML2UK6JCAS21321-89-1ChEMBLCHEMBL5095069ChEBI758653PubChem15633961

Structure

InChIKeyCHOUAXDNNAVGHR-NWSAAYAGSA-NSMILES[H][C@@]12CC[C@H](C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C

What you can answer from here — as of September 23, 2026

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Itruvone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account